Lana Medical issues prospectus to float 720,000 shares on Nomu

02/10/2023 Argaam
Logo ofLana Medical Co.

Logo of Lana Medical Co.


Lana Medical Co. issued today, Oct. 2, the prospectus to list 720,000 shares, or 20% of capital, on Nomu-Parallel Market.

 

The offering period for qualified investors will run for five days from Nov. 12-16.

 

The offering will be confined to qualified investors stipulated in the glossary of defined terms used in the regulations and rules of the CMA.

 

The company plans to use the IPO proceeds to set up two plants for medical waste processing in Abha and Hail, and complete the construction of Jeddah plant, according to the prospectus.

 

Lana Medical was established as a limited liability company in Riyadh in 2010. It converted into a closed joint-stock company in 2020. It currently operates with SAR 30 million capital.

 

The company's activities, as stated in its Articles of Association, are to engage in all aspects of activities related to the medical fields, including medical industries, therapeutic services, other related and complementary industries, and any other activity, including treating and recycling medical waste, inside Saudi Arabia and abroad.

 

Lana Medical’s activities, as stated in its commercial register, include manufacturing of disinfectants and sterilizers for medical devices and products, surgical and fracture dressings, medical padding, surgical sutures, medical cotton, pharmaceutical materials used in the production of medicines and pharmaceutical materials used in the manufacture of vitamins.

 

The company also manufactures health or pharmaceutical items from rubber, cans and boxes from plastics, bags from plastics, equipment, tubes, regular radiological devices and parts thereof for medical, scientific and research purposes, and others.

 

In June, the Capital Market Authority (CMA) approved the application submitted by the company to register and offer 720,000 shares on Nomu.

 

Company Profile

Company

Lana Medical Co.

Market

Nomu-Parallel Market

Core Activities

Medical industries

Capital before IPO

SAR 30 mln

Capital after IPO

SAR 36 mln

 

IPO Summary

Issue Percentage

20%

Offered shares

720,000

Minimum Limit

10 shares

Maximum Limit

179,990 shares

Offer period

Nov. 12-16, 2023

Final Allocation

Nov. 21, 2023

Refund (if any)

Nov. 23, 2023

 

Company Shareholders

Shareholders

Before-IPO

Post-IPO

Number of Shares

(‘000)

Ownership

(%)

Number of Shares

(‘000)

Ownership

(%)

Mohamed Abdullah Abdul Rahman Al Sheeha

750.00

25.00%

720.00

20.00%

Khalid Saleh Ibrahim Al Fawzan

690.00

23.00%

662.40

18.40%

Suleiman Saleh Ibrahim Al Fawzan

690.00

23.00%

662.40

18.40%

Mohammed Abdul Karim Al Matroudi

67.65

2.25%

64.94

1.80%

Other shareholders (owning less than 5% of capital)

802.35

26.75%

770.26

21.40%

Qualified Investors

--

--

720.00

20.00%

Total

3000.00

100%

3600.00

100%

 

Additional Information

Financial Advisor and Lead Manager

Yaqeen Capital

 

For More IPOs

Comments {{getCommentCount()}}

Be the first to comment

loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.